Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121124172 | 12112417 | 2 | F | 20160818 | 20160225 | 20160826 | EXP | CA-AMGEN-CANSP2016021891 | AMGEN | 47.00 | YR | A | F | Y | 0.00000 | 20160825 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121124172 | 12112417 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | N | 103795 | UNKNOWN FORMULATION | ||||||||
| 121124172 | 12112417 | 2 | SS | ENBREL | ETANERCEPT | 1 | N | 103795 | UNKNOWN FORMULATION | ||||||||||
| 121124172 | 12112417 | 3 | SS | GOLD | GOLD | 1 | Unknown | UNK | 0 | INJECTION | |||||||||
| 121124172 | 12112417 | 4 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 121124172 | 12112417 | 5 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 121124172 | 12112417 | 6 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 121124172 | 12112417 | 7 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | UNK | 0 | ||||||||||
| 121124172 | 12112417 | 8 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK | 0 | ||||||||||
| 121124172 | 12112417 | 9 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121124172 | 12112417 | 1 | Rheumatoid arthritis |
| 121124172 | 12112417 | 2 | Juvenile idiopathic arthritis |
| 121124172 | 12112417 | 3 | Rheumatoid arthritis |
| 121124172 | 12112417 | 4 | Rheumatoid arthritis |
| 121124172 | 12112417 | 5 | Rheumatoid arthritis |
| 121124172 | 12112417 | 6 | Rheumatoid arthritis |
| 121124172 | 12112417 | 7 | Rheumatoid arthritis |
| 121124172 | 12112417 | 8 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121124172 | 12112417 | DS |
| 121124172 | 12112417 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121124172 | 12112417 | Condition aggravated | |
| 121124172 | 12112417 | Disability | |
| 121124172 | 12112417 | Drug effect decreased | |
| 121124172 | 12112417 | Drug ineffective | |
| 121124172 | 12112417 | Fatigue | |
| 121124172 | 12112417 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121124172 | 12112417 | 1 | 2006 | 20160216 | 0 |